Related Experiment Video
Updated: May 10, 2025

Analysis of Craniomaxillofacial Malformations in Mice Using Three-dimensional Microcomputed Tomography
Published on: January 17, 2025
Craniofacial Changes Among Children and Adolescents Submitted to Growth Hormone Therapy: A Systematic Review
Raul Borges Nascimento1, Suelly Maria Mendes Ribeiro2, Nathalia Carolina Fernandes Fagundes2
1Faculty of Dentistry, Federal University of Pará, Belém, Brazil.
Insights
Growth hormone (GH) therapy in children with GH deficiency or idiopathic short stature (ISS) showed a small, clinically insignificant increase in mandibular dimensions. More long-term studies are needed to confirm effects on craniofacial growth.
Area of Science:
- Pediatric Endocrinology
- Craniofacial Biology
- Systematic Review Methodology
Background:
- Growth hormone (GH) therapy is used for children with GH deficiency or idiopathic short stature (ISS).
- Understanding the impact of GH therapy on craniofacial development is crucial for monitoring treatment outcomes.
- Previous research has yielded varied results regarding craniofacial changes during GH therapy.
Purpose of the Study:
- To systematically review the association between craniofacial changes and GH therapy in pediatric populations with GH deficiency or ISS.
- To synthesize evidence on the effects of GH therapy on cephalometric measurements and dental age.
- To assess the risk of bias and certainty of evidence for included studies.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Electronic search across seven databases without year or language restrictions.
- Inclusion of studies on craniofacial changes in children/adolescents receiving GH therapy; risk of bias and evidence certainty assessed using JBI, RoB 2.0, and GRADE tools.
Main Results:
- Seven studies met eligibility criteria from 4494 identified citations.
- GH therapy showed a small, clinically insignificant increase in mandibular dimensions.
- No significant differences were found in maxillary and mandibular dimensions between immediate and delayed treatments.
- Low risk of bias and low certainty of evidence were observed across all outcomes.
Conclusions:
- GH therapy may lead to a slight increase in mandibular and maxillary dimensions without significant adverse health effects.
- Current evidence suggests minimal clinical impact on craniofacial growth.
- Further controlled intervention studies with long-term follow-up are necessary to establish precise recommendations.
Abstract:
The aim of this systematic review was to investigate the association between craniofacial changes and growth hormone (GH) therapy among children and adolescents with GH deficiency or idiopathic short stature (ISS). The PRISMA guideline was followed to carry out all stages of this review. An electronic search was conducted in seven databases, without year or language restrictions. The study selection was carried out in two stages by two calibrated examiners. Studies exploring craniofacial changes among children and adolescents with GH deficiency or ISS undergoing GH therapy were included. After data extraction, the risk of bias was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal tool and the RoB 2.0 Checklist. The certainty of the evidence was assessed using the GRADE tool. Among the 4494 identified citations, seven studies met the eligibility criteria. These studies evaluated the impact of GHs on cephalometric measurements and dental age. No differences between immediate and delayed treatments were found in maxillary and mandibular dimensions. All selected articles showed a low risk of bias. A low certainty of evidence was observed for all outcomes assessed. GH therapy appears to result in a small increase in mandibular dimensions, although without clinical significance characteristic of adverse effects. Clinical trials and long-term follow-up studies of these patients are needed to develop accurate recommendations regarding the effects of GHs in the craniofacial region. Growth hormone may result in a slight increase in mandibular and maxillary dimensions, without significant adverse effects to general health. Controlled intervention studies with long-term follow-up are needed to establish more precise recommendations. Trial Registration: PROSPERO database (https://www.crd.york.ac.uk/prospero/): CRD42024511329.
Related Concept Videos
Signs of Puberty
Nature and Nurture
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Sutures of the Skull
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...

